These emerging medications , Tirzepatide , represent a significant advancement in treating type 2 diabetes and potentially related conditions . They are classified as GLP-1 receptor activators , indicating these substances to mimic the natural GLP-1 substance , stimulating insulin release and lowering food intake. Although Tirzepatide every functio